A Senate review led by Sen. Ron Johnson is examining how federal officials handled reports of possible COVID-19 vaccine side effects, including whether safety signals identified through the nation's vaccine reporting system were adequately disclosed to the public.
Questions surrounding the federal government's monitoring of COVID-19 vaccine safety have resurfaced as a Senate review led by Sen. Ron Johnson scrutinizes the Vaccine Adverse Event Reporting System (VAERS) and how reports of potential side effects were handled during the pandemic.
The review is examining the role of VAERS—a national vaccine safety monitoring system jointly managed by the Centers for Disease Control and Prevention and the Food and Drug Administration—and whether federal health officials responded appropriately to reports submitted during the COVID-19 vaccine rollout
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
